[Diagnosis and treatment of 41 patients with malignant peritoneal mesothelioma].
OBJECTIVE
To study the methods of diagnosis and treatment of malignant peritoneal mesothelioma.


METHODS
The clinical data of 41 patients with malignant peritoneal mesothelioma pathologically confirmed were retrospectively analyzed.


RESULTS
Of these 41 patients, abdominal pain and diarrhea were found in 38 and 35. The histopathologic types were: epitheloid, fusiform and mixed in 21, 11 and 9 cases. CT was performed in 21 and laparoscopic exploration in 13. The overall surgical resection rate was 70.7%. After operation, local abdominal cavity chemotherapeutic instillation was given in 12, systemic chemotherapy in 23 and immunotherapy in 3. The two year survival rate was 36.6%.


CONCLUSIONS
For malignant peritoneal mesothelioma, the final diagnosis depends on histological examination and the treatment should be surgical-core combined methods.
Zhang
Zhong-guo
ZG
Department of General Surgery, Tumor Hospital, Tianjin Medical University, Tianjin 300060, China. doctorchina@eyou.com
Hao
Xi-shan
XS
D000328:Adult; D000368:Aged; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D002945:Cisplatin / Q000627:therapeutic use*; D003131:Combined Modality Therapy; D003937:Diagnosis, Differential; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D010535:Laparoscopy; D008297:Male; D008654:Mesothelioma / Q000175:diagnosis / Q000188:drug therapy / Q000601:surgery; D008875:Middle Aged; D010534:Peritoneal Neoplasms / Q000175:diagnosis / Q000188:drug therapy / Q000601:surgery; D012189:Retrospective Studies; D015996:Survival Rate; D014057:Tomography, X-Ray Computed
D000970:Antineoplastic Agents; D002945:Cisplatin